ID   2211M
AC   CVCL_WM38
DR   cancercelllines; CVCL_WM38
DR   Cosmic; 852213
DR   IARC_TP53; 20613
DR   Wikidata; Q93302168
RX   PubMed=15195137;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro246Ser (c.737C>T); Zygosity=Unspecified (PubMed=15195137).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser127Phe (c.380_381CC>TT); Zygosity=Unspecified (PubMed=15195137).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
RX   PubMed=15195137; DOI=10.1038/sj.onc.1207780;
RA   Daniotti M., Oggionni M., Ranzani T., Vallacchi V., Campi V.,
RA   Di Stasi D., Della Torre G., Perrone F., Luoni C., Suardi S.,
RA   Frattini M., Pilotti S., Anichini A., Tragni G., Parmiani G.,
RA   Pierotti M.A., Rodolfo M.;
RT   "BRAF alterations are associated with complex mutational profiles in
RT   malignant melanoma.";
RL   Oncogene 23:5968-5977(2004).
//